Erweiterte Suche

Gegenwärtig ist Birgitte Volck SVP, Head-Clinical Development & Medical Affairs bei Ascendis Pharma A. Dr. Volck ist außerdem Mitglied des Vorstands von Soleno Therapeutics, Inc. und Vaccibody AS. Zuvor war Dr. Volck Leiterin der Forschung und Entwicklung bei GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development bei Swedish Orphan Biovitrum AB, President-Research & Development bei Avrobio, Inc, Director-Executive Development bei Amgen, Inc, Director-Nordic Medical & Project Director bei Genzyme Danmark und Head-Clinical Development & Medical Affairs bei Pharmexa A. Birgitte Volck promovierte an der Universität von Kopenhagen.

Birgitte Bonnesen served as the President & Chief Executive Officer at Swedbank AB from 2016 to 2019.
Prior to that, she worked at Swedbank AB for over 30 years.
Bonnesen holds an MBA from the Stockholm School of Economics and a graduate degree from the University of Aarhus.

Birgitte Kræmmergaard was the Chief Executive Officer at Zealand Care A.

Birgitte Lorentzen worked as a Director at SpareBank 1 Helgeland.
She obtained an undergraduate degree from Norges Markedshøyskole and another undergraduate degree from Politihøgskolen.

Birgitte Stephensen is currently working as the Chief Legal Officer & Executive Vice President at Genmab A since 2002.
She graduated from Danmarks Farmaceutiske Universitet.

Birgitte Jacobsen has worked as a Director at BIMO ApS and as a Co-Managing Director at Visit Beyond ApS from 2004 to present.

Birgitte Rosendahl has a current job as a Director at Egmont Publishing A since 2018.

Birgitte Kvalevåg Øversjøen has a current job as an Analyst at DNB Bank ASA (Broker).

Ms. Birgitte Kolrud is on the Board of Directors at Nettpartner AS.
Ms. Kolrud was previously employed as a Senior Investment Manager by Norfund.

Ms. Birgitte Olsen, CFA, is a Lead Portfolio Manager at Bellevue Asset Management AG.
She is also a Senior Portfolio Manager for European Equities.
She joined the firm in 2008.
She previously spent over nine years at Generali Investments in Cologne as Deputy Head of Equities, managing European portfolios and thematic funds.

Birgitte Norup currently works as a Manager-Human Resources at ESS-FOOD A.

Birgitte Schou currently works at Schou Co. A, as Director and HP Schou Holding A, as Director.

Birgitte Jeppesen has worked as a Director at Hornsyld Ejendomme.
AS since 2004.

Birgitte Brinch Madsen is currently the Vice Chairman at DEIF A.
She also holds several non-executive director positions, including at John Wood Group Plc, Arkil Holding A, Investeringsforeningen Danske Invest, Investeringsforeningen Danske Invest Select, and Danske Invest Select.
Previously, she worked as the Director of Energy & Industry Business at COWI A and as the Chief Technical Officer at Maersk A and Maersk FPSOs A.
She graduated from the University of Copenhagen.

Birgitte Nauntofte is currently the Vice Chairman at Steno Diabetes Center A, Director at The Danish Council For Research Policy, and a Member at Denmark Ministry of Education.
She was previously the Chief Executive Officer & Director at Novo Nordisk Fonden, Chairman at The Kennedy Collective Inc, Director at Danmarks Farmaceutiske Universitet, Professor-Clinical Oral Physiology at the University of Copenhagen, and a Member at Noregs forskingsråd and Denmark Ministry of Higher Edcation & Science.
She received her doctorate degree from the University of Copenhagen in 1993.

Birgitte Andersen founded Signal Arkitekter ApS in 2000, where she worked as Chief Executive Officer.
Ms. Andersen also currently works at Bro Kommunikation A, as Director from 2018.

Birgitte Lundeby Kolstad has worked as a Senior Associate at HitecVision Private Equity AS since 2020 and as a Senior Financial Analyst at Copenhagen Infrastructure Partners P since 2018.

Birgitte Karlsen formerly worked at Aker Offshore Wind AS, as General Counsel.
Ms. Karlsen received her graduate degree in 2002 from the University of Bergen.

Birgitte Rønnow has founded Terranol A in 2007, where she currently holds the title of Chief Executive Officer.
She previously worked as a Principal at DuPont Nutrition Biosciences ApS.
Dr. Rønnow earned a doctorate degree from the University of Copenhagen in 1992.

Birgitte Engleder is currently the Managing Director at Engel Gesellschaft mbH, a Member-Supervisory Board at KURIER Beteiligungs-AG, and a Managing Partner at EBS Beteiligungs GmbH.
Previously, she was an Independent Member-Supervisory Board at Oberbank AG from 2006 to 2011.